Martin James Sams,Juliet Victoria High,Paul Andrew Jamieson,Clive Booles
申请号：
US14367312
公开号：
US20150005307A1
申请日:
2012.12.19
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention provides a pharmaceutical composition for the transmucosal delivery of a PDE5 inhibitor, said composition comprising a PDE5 inhibitor and a carrier in which said PDE5 inhibitor is soluble or forms a suspension or emulsion. The invention also provides a pharmaceutical composition comprising a PDE5 inhibitor for use in inhibiting PDE activity in vivo, where in said use said composition is delivered by the transmucosal route.
